No cytomegalovirus-related deaths after non-ablative stem cell allografts

Hematology

Volumn 7, Issue 2, 2002, Pages 95-99

  Ruiz Argüelles, Guillermo J ^d   Gómez Almaguer, David ^a   López Martínez, Briceida ^b   Ponce de León, Samuel ^c   Cantú Rodriguez, Olga G ^a   Jaime Pérez, José C ^a  

^a HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^b CENTRO DE HEMATOLOGÍA Y MEDICINA INTERNA DE PUEBLA   (Mexico)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^d NONE

Author keywords

Cytomegalovirus; Death; Disease; Non myeloablative; Stem cell transplantation

Indexed keywords

ANTIBIOTIC AGENT; BUSULFAN; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOMEGALOVIRUS ANTIBODY; FLUDARABINE; GANCICLOVIR; IMMUNOGLOBULIN G; ITRACONAZOLE; METHOTREXATE; ONDANSETRON; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; VIRUS ANTIBODY;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; BONE MARROW DEPRESSION; CANCER MORTALITY; CANCER RECURRENCE; CHILD; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DEATH; DONOR; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNITY; MALE; MEDICAL ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; RECIPIENT; SURVIVAL TIME; THALASSEMIA; ALLOTRANSPLANTATION; BLOOD; BLOOD DISEASE; CHEMICALLY INDUCED DISORDER; CYTOMEGALIC INCLUSION BODY DISEASE; IMMUNOSUPPRESSIVE TREATMENT; METHODOLOGY; MIDDLE AGED; MORTALITY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0036284071     PISSN: 10245332     EISSN: None     Source Type: Journal    
DOI: 10.1080/10245330290022106     Document Type: Article

References (22)

1. "Bone marrow transplantation in malignant disease"
2. "Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeoablative therapy"
3. "Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematological diseases"
4. "Engraftment of HLA-matched sibling hematopoietic stem cells after immunosuppressive conditioning regimen in patients with hematologic neoplasias"
5. "Outpatient allografting with minimally myelosuppressive, immunosuppressive conditioning of low-dose TBI and post-grafting cyclosporine and mycophenolate mofetil"
6. "Nonmyeloablative transplants" preclinical and clinical results"
7. "Hematopoietic stem cell allografts using a nonmyeloablative conditioning regimen can be safely performed on an outpatient basis"
8. "Results of an outpatient-based stem cell allotransplant program using non-myeloablative conditioning regimens"
9. "Allogeneic bone marrow transplantation with reduced conditioning"
10. "Outpatient programs of myeloablative chemotherapy, autologous and allogeneic bone marrow transplantation"
11. "Flow cytometry in the clinical laboratory. Principles, applications and problems"
12. "Caracterizacion y evaluación de células totipotenciales en sangre periférica y médula ósea"
13. "The Abbot IMX automated benchtop immunochemistry analyzer system"
14. "Cytomegalovirus infection after BMT"
15. "Complications of non-myeloablative stem cell transplantation"
16. "Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation"
17. "Cytomegalovirus reactivation and disease in myeloablative versus non-myeloablative allogeneic stem cell transplantation"
18. "The Mexican approach to conduct non-myeloablative stem cell transplantation"
19. "Low intensity regimens with allogeneic hematopoteic stem cell transplantation as treatment of hematologic neoplasia"
20. "Prevalence of cytomegalovirus infection among patients and blood donors at the Instituto National de Cancerología, México"
21. "Cytomegalovirus disease in adult marrow transplant recipients receiving ganciclovir prophylaxis: A retrospective study"
22. "Infectious complications within the first year after nonmyeloablative allogeneic peripheral blood stem cell transplantation"